PAIELLA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 11.657
EU - Europa 11.049
AS - Asia 7.730
SA - Sud America 1.154
AF - Africa 302
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 31.928
Nazione #
US - Stati Uniti d'America 11.377
RU - Federazione Russa 4.652
SG - Singapore 3.127
CN - Cina 2.065
IT - Italia 1.614
GB - Regno Unito 1.435
BR - Brasile 932
HK - Hong Kong 776
DE - Germania 711
VN - Vietnam 694
SE - Svezia 543
FR - Francia 510
IE - Irlanda 508
FI - Finlandia 278
KR - Corea 232
NL - Olanda 213
IN - India 174
CA - Canada 148
JP - Giappone 120
ES - Italia 112
MX - Messico 94
UA - Ucraina 89
BD - Bangladesh 82
AR - Argentina 80
TR - Turchia 76
ZA - Sudafrica 69
AT - Austria 66
PL - Polonia 64
IQ - Iraq 58
ID - Indonesia 57
NG - Nigeria 53
CZ - Repubblica Ceca 45
TG - Togo 38
PK - Pakistan 36
BE - Belgio 35
BJ - Benin 33
AU - Australia 28
EC - Ecuador 26
CO - Colombia 25
LT - Lituania 24
UZ - Uzbekistan 24
VE - Venezuela 24
MA - Marocco 23
SA - Arabia Saudita 23
CH - Svizzera 21
NP - Nepal 21
EG - Egitto 20
TN - Tunisia 20
PH - Filippine 19
PY - Paraguay 18
CL - Cile 17
IL - Israele 17
JO - Giordania 16
IR - Iran 13
PE - Perù 13
RO - Romania 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
AZ - Azerbaigian 12
KE - Kenya 12
HR - Croazia 11
HU - Ungheria 11
DK - Danimarca 10
LV - Lettonia 10
GR - Grecia 9
KG - Kirghizistan 9
BO - Bolivia 8
KZ - Kazakistan 8
PT - Portogallo 8
UY - Uruguay 8
CR - Costa Rica 7
ET - Etiopia 7
LB - Libano 7
MY - Malesia 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
NO - Norvegia 6
PA - Panama 6
RS - Serbia 6
BG - Bulgaria 5
DZ - Algeria 5
OM - Oman 5
SI - Slovenia 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GA - Gabon 4
GE - Georgia 4
GH - Ghana 4
GT - Guatemala 4
JM - Giamaica 4
PS - Palestinian Territory 4
CY - Cipro 3
EE - Estonia 3
GY - Guiana 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 31.879
Città #
Dallas 2.267
Moscow 1.733
Singapore 1.646
Ashburn 1.392
Southend 1.107
San Jose 1.087
Chandler 1.085
Hong Kong 764
Verona 613
Dublin 485
Beijing 387
The Dalles 305
New York 286
Los Angeles 265
Ho Chi Minh City 251
Woodbridge 239
Jacksonville 231
Munich 227
Houston 200
Ann Arbor 169
Hanoi 159
Council Bluffs 152
Lawrence 150
Princeton 150
Boardman 140
Helsinki 135
Wilmington 133
Jinan 115
Orem 113
São Paulo 108
Santa Clara 101
Tokyo 100
Nanjing 95
Buffalo 93
Shenyang 90
Redondo Beach 87
Milan 86
London 79
Seattle 75
Sindelfingen 75
Amsterdam 70
Montreal 67
Turku 63
Columbus 62
Redmond 61
Frankfurt am Main 59
Tianjin 59
Chennai 56
Hebei 55
Denver 52
Hangzhou 51
Warsaw 51
Abuja 47
Stockholm 46
Atlanta 45
Rome 45
Johannesburg 44
Fairfield 43
Bologna 42
Haikou 42
Toronto 41
Chicago 40
Ningbo 40
Nuremberg 40
Phoenix 40
Zhengzhou 39
Brooklyn 38
Changsha 38
Lomé 38
San Francisco 38
Falkenstein 35
Manchester 34
Redwood City 34
Seoul 34
Washington 34
Cotonou 33
Guangzhou 33
Brussels 32
Mexico City 32
Nanchang 32
Vienna 32
Poplar 31
Brno 30
Da Nang 30
Taizhou 30
Lappeenranta 29
Mumbai 29
Taiyuan 29
Belo Horizonte 27
Paris 26
Boston 25
Meda 25
Rio de Janeiro 25
Falls Church 24
Jakarta 24
Barnet 22
Jiaxing 22
City of London 21
Haiphong 21
Tashkent 21
Totale 19.283
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 873
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 328
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe 291
Diffusion of Robotic Platforms and New Devices in HPB Surgery: A European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Survey 270
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 256
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 255
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 238
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 237
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 233
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 233
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 232
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 221
A root-cause analysis of mortality following major pancreatectomy 221
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 214
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 213
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 213
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 211
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 209
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 208
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 208
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 204
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 204
Delaying surgery for patients with a previous SARS-CoV-2 infection 202
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 199
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 197
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 195
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 194
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 192
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 188
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 186
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 184
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 183
Ablation treatments in unresectable pancreatic cancer 182
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 181
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 179
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 176
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 175
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 175
Fhit down-regulation is an early event in pancreatic carcinogenesis 174
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 174
Minimally invasive pancreatic surgery - a review 173
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 173
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 173
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 173
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 173
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 169
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 168
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 168
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 167
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 167
Sex differences in oncogenic mutational processes 166
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 166
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 165
The management of intraductal papillary mucinous neoplasms of the pancreas 165
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 165
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 164
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 163
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 163
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 163
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 162
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 161
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 161
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 161
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 160
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 160
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 158
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 157
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 156
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 156
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 155
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 154
Local ablation disrupts immune evasion in pancreatic cancer 154
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 154
An Antibiotic Stewardship Program in Pancreatic Surgery 154
ESGAR 2018 Book of Abstracts 153
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 152
Percutaneous ablation of pancreatic cancer 151
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 151
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 150
Surgery for Distal Cholangiocarcinoma 149
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy 148
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 147
Radiofrequency Ablation of Pancreatic Cancer 147
The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis 147
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 147
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 146
Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort 146
Totale 19.426
Categoria #
all - tutte 104.936
article - articoli 99.774
book - libri 0
conference - conferenze 1.841
curatela - curatele 0
other - altro 299
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.022
Totale 209.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 0 0 0 0 41 94 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/20255.118 283 273 232 776 269 153 326 282 671 370 522 961
2025/202616.914 1.032 1.140 2.035 2.710 4.114 1.074 1.446 1.006 1.411 946 0 0
Totale 32.284